Artivion Inc (FRA:CYL)
€ 26.75 0.1 (0.38%) Market Cap: 1.14 Bil Enterprise Value: 1.43 Bil PE Ratio: 0 PB Ratio: 3.89 GF Score: 74/100

Q3 2021 CryoLife Inc Earnings Call Transcript

Nov 04, 2021 / 08:30PM GMT
Release Date Price: €18.3 (+2.23%)
Operator

Good day, ladies and gentlemen, and welcome to the CryoLife Third Quarter 2021 Financial Conference Call. (Operator Instructions)

At this time, it is my pleasure to turn the floor over to your host, Brian Johnston. Sir, the floor is yours.

James Patrick Mackin
CryoLife, Inc. - Chairman, President & CEO

This is Pat Mackin, CEO of CryoLife. We posted a solid quarter despite the headwinds caused by the Delta variant. Our results for the third quarter were $72.2 million, 5% growth on a pro forma constant currency basis compared to Q3 2019, which were right in the midpoint of our Q3 guidance. Our performance benefited particularly from our new stent and stent grafts product launches and strength in our On-X aortic valve business in the U.S.

More specifically, in the third quarter of 2021 compared to the third quarter of 2019, our stents and stent graft segment grew 22% and On-X grew 10%, each on a pro forma constant currency basis. The On-X product line growth was led by the On-X aortic valve revenue growth in North America, which grew 16%

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot